Selected research
Industry Growth & Trends
Global Pharmaceutical Serialisation Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pharmaceutical Serialisation Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Serialisation Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pharmaceutical Serialisation Services market include Movianto, UPM Pharmaceuticals, MSK Pharmalogisti, Covectra, Koerber-Pharma, Palladio Group, TraceLink, Ultimate Solutions and Clarkston Consulting, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharmaceutical Serialisation Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharmaceutical Serialisation Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Serialisation Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Serialisation Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Serialisation Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharmaceutical Serialisation Services Market by Company
Movianto
UPM Pharmaceuticals
MSK Pharmalogisti
Covectra
Koerber-Pharma
Palladio Group
TraceLink
Ultimate Solutions
Clarkston Consulting
Jones Healthcare Group
MSK Pharmalogistic
Vetter-Pharma
NextPharma Logistics
OPTEL
Central Pharma
Aphena Pharma +C581Solutions
NNE
Sharp Services
Pharmaceutical Serialisation Services Segment by Type
Barcode
QR Code
RFID
Others
Pharmaceutical Serialisation Services Segment by Application
Pharmaceutical Manufacturing
Pharmaceutical Distribution
Pharmaceutical Logistics
Pharmaceutical Serialisation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Serialisation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Serialisation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Serialisation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharmaceutical Serialisation Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Barcode
- QR Code
- RFID
- Others
Applications
- Pharmaceutical Manufacturing
- Pharmaceutical Distribution
- Pharmaceutical Logistics
Companies covered
- Movianto
- UPM Pharmaceuticals
- MSK Pharmalogisti
- Covectra
- Koerber-Pharma
- Palladio Group
- TraceLink
- Ultimate Solutions
- Clarkston Consulting
- Jones Healthcare Group
- MSK Pharmalogistic
- Vetter-Pharma
- NextPharma Logistics
- OPTEL
- Central Pharma
- Aphena Pharma +C581Solutions
- NNE
- Sharp Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharmaceutical Serialisation Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharmaceutical Serialisation Services Market Size by Region (2021-2032)
- 1.4.1 Global Pharmaceutical Serialisation Services Market Size by Region (2021-2026)
- 1.4.2 Global Pharmaceutical Serialisation Services Market Size by Region (2027-2032)
- 1.5 Key Regions Pharmaceutical Serialisation Services Market Size (2021-2032)
- 1.5.1 North America Pharmaceutical Serialisation Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharmaceutical Serialisation Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharmaceutical Serialisation Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharmaceutical Serialisation Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharmaceutical Serialisation Services Market Size Growth Rate (2021-2032)
2 Pharmaceutical Serialisation Services Market by Type
- 2.1 Type Introduction
- 2.1.1 Barcode
- 2.1.2 QR Code
- 2.1.3 RFID
- 2.1.4 Others
- 2.2 Global Pharmaceutical Serialisation Services Market Size by Type
- 2.2.1 Global Pharmaceutical Serialisation Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharmaceutical Serialisation Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharmaceutical Serialisation Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharmaceutical Serialisation Services Market Size by Regions
- 2.3.1 North America Pharmaceutical Serialisation Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharmaceutical Serialisation Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharmaceutical Serialisation Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharmaceutical Serialisation Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharmaceutical Serialisation Services Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Serialisation Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Manufacturing
- 3.1.2 Pharmaceutical Distribution
- 3.1.3 Pharmaceutical Logistics
- 3.2 Global Pharmaceutical Serialisation Services Market Size by Application
- 3.2.1 Global Pharmaceutical Serialisation Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharmaceutical Serialisation Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharmaceutical Serialisation Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharmaceutical Serialisation Services Market Size by Regions
- 3.3.1 North America Pharmaceutical Serialisation Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharmaceutical Serialisation Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharmaceutical Serialisation Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharmaceutical Serialisation Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharmaceutical Serialisation Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharmaceutical Serialisation Services Industry Trends
- 4.2 Pharmaceutical Serialisation Services Industry Drivers
- 4.3 Pharmaceutical Serialisation Services Industry Opportunities and Challenges
- 4.4 Pharmaceutical Serialisation Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharmaceutical Serialisation Services Revenue (2021-2026)
- 5.2 Global Pharmaceutical Serialisation Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharmaceutical Serialisation Services Key Company Headquarters & Area Served
- 5.4 Global Pharmaceutical Serialisation Services Company, Product Type & Application
- 5.5 Global Pharmaceutical Serialisation Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharmaceutical Serialisation Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharmaceutical Serialisation Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharmaceutical Serialisation Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Movianto
- 6.1.1 Movianto Company Information
- 6.1.2 Movianto Business Overview
- 6.1.3 Movianto Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Movianto Pharmaceutical Serialisation Services Product Portfolio
- 6.1.5 Movianto Recent Developments
- 6.2 UPM Pharmaceuticals
- 6.2.1 UPM Pharmaceuticals Company Information
- 6.2.2 UPM Pharmaceuticals Business Overview
- 6.2.3 UPM Pharmaceuticals Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 UPM Pharmaceuticals Pharmaceutical Serialisation Services Product Portfolio
- 6.2.5 UPM Pharmaceuticals Recent Developments
- 6.3 MSK Pharmalogisti
- 6.3.1 MSK Pharmalogisti Company Information
- 6.3.2 MSK Pharmalogisti Business Overview
- 6.3.3 MSK Pharmalogisti Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 MSK Pharmalogisti Pharmaceutical Serialisation Services Product Portfolio
- 6.3.5 MSK Pharmalogisti Recent Developments
- 6.4 Covectra
- 6.4.1 Covectra Company Information
- 6.4.2 Covectra Business Overview
- 6.4.3 Covectra Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Covectra Pharmaceutical Serialisation Services Product Portfolio
- 6.4.5 Covectra Recent Developments
- 6.5 Koerber-Pharma
- 6.5.1 Koerber-Pharma Company Information
- 6.5.2 Koerber-Pharma Business Overview
- 6.5.3 Koerber-Pharma Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Koerber-Pharma Pharmaceutical Serialisation Services Product Portfolio
- 6.5.5 Koerber-Pharma Recent Developments
- 6.6 Palladio Group
- 6.6.1 Palladio Group Company Information
- 6.6.2 Palladio Group Business Overview
- 6.6.3 Palladio Group Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Palladio Group Pharmaceutical Serialisation Services Product Portfolio
- 6.6.5 Palladio Group Recent Developments
- 6.7 TraceLink
- 6.7.1 TraceLink Company Information
- 6.7.2 TraceLink Business Overview
- 6.7.3 TraceLink Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 TraceLink Pharmaceutical Serialisation Services Product Portfolio
- 6.7.5 TraceLink Recent Developments
- 6.8 Ultimate Solutions
- 6.8.1 Ultimate Solutions Company Information
- 6.8.2 Ultimate Solutions Business Overview
- 6.8.3 Ultimate Solutions Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Ultimate Solutions Pharmaceutical Serialisation Services Product Portfolio
- 6.8.5 Ultimate Solutions Recent Developments
- 6.9 Clarkston Consulting
- 6.9.1 Clarkston Consulting Company Information
- 6.9.2 Clarkston Consulting Business Overview
- 6.9.3 Clarkston Consulting Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Clarkston Consulting Pharmaceutical Serialisation Services Product Portfolio
- 6.9.5 Clarkston Consulting Recent Developments
- 6.10 Jones Healthcare Group
- 6.10.1 Jones Healthcare Group Company Information
- 6.10.2 Jones Healthcare Group Business Overview
- 6.10.3 Jones Healthcare Group Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Jones Healthcare Group Pharmaceutical Serialisation Services Product Portfolio
- 6.10.5 Jones Healthcare Group Recent Developments
- 6.11 MSK Pharmalogistic
- 6.11.1 MSK Pharmalogistic Company Information
- 6.11.2 MSK Pharmalogistic Business Overview
- 6.11.3 MSK Pharmalogistic Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 MSK Pharmalogistic Pharmaceutical Serialisation Services Product Portfolio
- 6.11.5 MSK Pharmalogistic Recent Developments
- 6.12 Vetter-Pharma
- 6.12.1 Vetter-Pharma Company Information
- 6.12.2 Vetter-Pharma Business Overview
- 6.12.3 Vetter-Pharma Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Vetter-Pharma Pharmaceutical Serialisation Services Product Portfolio
- 6.12.5 Vetter-Pharma Recent Developments
- 6.13 NextPharma Logistics
- 6.13.1 NextPharma Logistics Company Information
- 6.13.2 NextPharma Logistics Business Overview
- 6.13.3 NextPharma Logistics Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 NextPharma Logistics Pharmaceutical Serialisation Services Product Portfolio
- 6.13.5 NextPharma Logistics Recent Developments
- 6.14 OPTEL
- 6.14.1 OPTEL Company Information
- 6.14.2 OPTEL Business Overview
- 6.14.3 OPTEL Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 OPTEL Pharmaceutical Serialisation Services Product Portfolio
- 6.14.5 OPTEL Recent Developments
- 6.15 Central Pharma
- 6.15.1 Central Pharma Company Information
- 6.15.2 Central Pharma Business Overview
- 6.15.3 Central Pharma Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Central Pharma Pharmaceutical Serialisation Services Product Portfolio
- 6.15.5 Central Pharma Recent Developments
- 6.16 Aphena Pharma +C581Solutions
- 6.16.1 Aphena Pharma +C581Solutions Company Information
- 6.16.2 Aphena Pharma +C581Solutions Business Overview
- 6.16.3 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Aphena Pharma +C581Solutions Pharmaceutical Serialisation Services Product Portfolio
- 6.16.5 Aphena Pharma +C581Solutions Recent Developments
- 6.17 NNE
- 6.17.1 NNE Company Information
- 6.17.2 NNE Business Overview
- 6.17.3 NNE Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 NNE Pharmaceutical Serialisation Services Product Portfolio
- 6.17.5 NNE Recent Developments
- 6.18 Sharp Services
- 6.18.1 Sharp Services Company Information
- 6.18.2 Sharp Services Business Overview
- 6.18.3 Sharp Services Pharmaceutical Serialisation Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Sharp Services Pharmaceutical Serialisation Services Product Portfolio
- 6.18.5 Sharp Services Recent Developments
7 North America
- 7.1 North America Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 7.3 North America Pharmaceutical Serialisation Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 8.3 Europe Pharmaceutical Serialisation Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharmaceutical Serialisation Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 10.3 South America Pharmaceutical Serialisation Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Serialisation Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharmaceutical Serialisation Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharmaceutical Serialisation Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst